000 01427 a2200397 4500
005 20250516224108.0
264 0 _c20150710
008 201507s 0 0 eng d
022 _a1365-2265
024 7 _a10.1111/cen.12566
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSanthanam, Prasanna
245 0 0 _aRole of (18) F-FDOPA PET/CT imaging in endocrinology.
_h[electronic resource]
260 _bClinical endocrinology
_cDec 2014
300 _a789-98 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Gland Neoplasms
_xdiagnostic imaging
650 0 4 _aCarbidopa
650 0 4 _aCarcinoid Tumor
_xdiagnostic imaging
650 0 4 _aCarcinoma, Neuroendocrine
650 0 4 _aDihydroxyphenylalanine
_xanalogs & derivatives
650 0 4 _aDopamine Agents
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aMultimodal Imaging
650 0 4 _aNeuroendocrine Tumors
_xdiagnostic imaging
650 0 4 _aParaganglioma
_xdiagnostic imaging
650 0 4 _aPheochromocytoma
_xdiagnostic imaging
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRadiopharmaceuticals
650 0 4 _aThyroid Neoplasms
_xdiagnostic imaging
650 0 4 _aTomography, X-Ray Computed
700 1 _aTaïeb, David
773 0 _tClinical endocrinology
_gvol. 81
_gno. 6
_gp. 789-98
856 4 0 _uhttps://doi.org/10.1111/cen.12566
_zAvailable from publisher's website
999 _c24037952
_d24037952